A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
Clinical trial NCT05081557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05081557
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-17
- Primary completion
- 2026-10-01
- Enrollment
- 873
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.